Cell Growth & Differentiation, Vol 5, Issue 8 873-880, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Distinct responses of protein kinase C isozymes to c-erbB-2 activation in SKBR-3 human breast carcinoma cells

MH Disatnik, AR Winnier, D Mochly-Rosen and CL Arteaga
Department of Molecular Pharmacology, Stanford University, California 94305-5332.

We have studied the effect of activation of the c-erbB-2 receptor tyrosine kinase on protein kinase C (PKC) in cultured SKBR-3 human breast cancer cells. Treatment with the agonistic anti-receptor monoclonal antibody TAb 250 induces receptor autophosphorylation and stimulates phospholipase C-gamma 1 (L. K. Shawver et al. Cancer Res., 54: 1367-1373, 1994). TAb 250 induced a rapid and marked translocation of PKC histone phosphorylation activity to the particulate fraction of SKBR-3 cells. By immunoblot, however, this translocation was limited to specific PKC isozymes. beta PKC and zeta PKC translocated to the particulate fraction, whereas epsilon PKC underwent "partial reversed translocation" to the cell soluble fraction after receptor stimulation. Furthermore, beta PKC was rapidly degraded following TAb 250 treatment. By immunocytochemistry, beta IPKC translocated from the perinuclear area to the cytosol and into the nucleus, whereas zeta PKC translocated to the perinuclear region and into the nucleus. Consistent with the Western blot results, epsilon PKC translocated from the nucleus to the perinuclear area and the cytosol. These changes in the localization of PKC isozymes were not observed after addition of normal IgG1 or a nonagonistic anti-c-erbB-2 monoclonal antibody to SKBR-3 cells. alpha, beta II, or delta PKC present in these cells did not translocate following receptor stimulation. These data indicate that c-erbB-2 signal transduction may involve the activation of specific PKC isozymes. The biological role of these enzymes in the phenotype and cellular responses of c-erbB-2-overexpressing carcinoma cells remains to be studied.

This article has been cited by other articles:

				J. Y. C. Chow, H. Dong, K. T. Quach, P. N. Van Nguyen, K. Chen, and J. M. Carethers TGF-{beta} mediates PTEN suppression and cell motility through calcium-dependent PKC-{alpha} activation in pancreatic cancer cells Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G899 - G905. [Abstract] [Full Text] [PDF]

				P. Acs, K. Bogi, P. S. Lorenzo, A. M. Marquez, T. Biro, Z. Szallasi, and P. M. Blumberg The Catalytic Domain of Protein Kinase C Chimeras Modulates the Affinity and Targeting of Phorbol Ester-induced Translocation J. Biol. Chem., August 29, 1997; 272(35): 22148 - 22153. [Abstract] [Full Text] [PDF]

				M. Yedovitzky, D. Mochly-Rosen, J. A. Johnson, M. O. Gray, D. Ron, E. Abramovitch, E. Cerasi, and R. Nesher Translocation Inhibitors Define Specificity of Protein Kinase C Isoenzymes in Pancreatic beta -Cells J. Biol. Chem., January 17, 1997; 272(3): 1417 - 1420. [Abstract] [Full Text] [PDF]

				D. Ron, J. Luo, and D. Mochly-Rosen C2 Region-derived Peptides Inhibit Translocation and Function of beta Protein Kinase C in Vivo J. Biol. Chem., October 13, 1995; 270(41): 24180 - 24187. [Abstract] [Full Text] [PDF]

				D Mochly-Rosen Localization of protein kinases by anchoring proteins: a theme in signal transduction Science, April 14, 1995; 268(5208): 247 - 251. [Abstract] [PDF]

				J. A. Johnson and D. Mochly-Rosen Inhibition of the Spontaneous Rate of Contraction of Neonatal Cardiac Myocytes by Protein Kinase C Isozymes : A Putative Role for the {varepsilon} Isozyme Circ. Res., April 1, 1995; 76(4): 654 - 663. [Abstract] [Full Text]